Your browser does not support JavaScript!
http://iet.metastore.ingenta.com
1887

access icon free Investigating receptor enzyme activity using time-scale analysis

At early drug discovery, purified protein-based assays are often used to characterise compound potency. In the context of dose response, it is often perceived that a time-independent inhibitor is reversible and a time-dependent inhibitor is irreversible. The legitimacy of this argument is investigated using a simple kinetics model, where it is revealed by model-based analytical analysis and numerical studies that dose response of an irreversible inhibitor may appear time-independent under certain parametric conditions. Hence, the observation of time-independence cannot be used as sole evidence for identification of inhibitor reversibility. It has also been discussed how the synthesis and degradation of a target receptor affect drug inhibition in an in vitro cell-based assay setting. These processes may also influence dose response of an irreversible inhibitor in such a way that it appears time-independent under certain conditions. Furthermore, model-based steady-state analysis reveals the complexity nature of the drug–receptor process.

References

    1. 1)
    2. 2)
    3. 3)
    4. 4)
      • 21. Hendriks, B.S., Opresko, L.K., Wiley, H.S., Lauffenburger, D.: ‘Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations quantitative analysis of HER2 overexpression effects’, Cancer Res., 2003, 63, (5), pp. 11301137.
    5. 5)
    6. 6)
      • 20. Lauffenburger, D.A., Linderman, J.J.: ‘Receptors: models for binding, trafficking, and signaling’ (Oxford University Press, New York, 1993).
    7. 7)
    8. 8)
    9. 9)
    10. 10)
      • 1. Sorger, P.K., Allerheiligen, S.R., Abernethy, D.R., et al: ‘Quantitative and systems pharmacology in the post-genomic era: new approaches to discovering drugs and understanding therapeutic mechanisms’. An NIH White Paper by the QSP Workshop Group, NIH, Bethesda, 2011, pp. 148.
    11. 11)
      • 9. Orrell, D., Fernandez, E.: ‘Using predictive mathematical models to optimise the scheduling of anti-cancer drugs’, Innov. Pharm. Technol., 2010, 33, pp. 5862.
    12. 12)
    13. 13)
    14. 14)
    15. 15)
    16. 16)
    17. 17)
    18. 18)
    19. 19)
      • 16. Strelow, J., Dewe, W., Iversen, P., et al: ‘Mechanism of action assays for enzymes’, 2004.
    20. 20)
    21. 21)
    22. 22)
http://iet.metastore.ingenta.com/content/journals/10.1049/iet-syb.2015.0037
Loading

Related content

content/journals/10.1049/iet-syb.2015.0037
pub_keyword,iet_inspecKeyword,pub_concept
6
6
Loading
This is a required field
Please enter a valid email address